News
Shortcuts from other journals
New anticoagulant gets mixed results
BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7620.586 (Published 20 September 2007) Cite this as: BMJ 2007;335:586
Idraparinux is a new anticoagulant that inhibits activated factor X. It has a long half life and can be given just once a week, by subcutaneous injection. But is it as good as standard anticoagulants at preventing recurrent venous thromboembolism⇑? …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.